First Quarter 2024 Results

Q1 2024 Media Update

First-quarter performance as expected
  • Group sales at 13.765 billion euros (Fx & p adj. minus 0.6 percent), currency headwinds of 525 million euros
  • EBITDA before special items falls 1.3 percent to 4.412 billion euros
  • Sales and earnings down at Crop Science and Consumer Health
  • Pharmaceuticals posts higher sales and earnings
  • Core earnings per share at 2.82 euros (minus 4.4 percent)
  • Net income at 2.0 billion euros
  • Free cash flow at minus 2.626 billion euros
  • Currency-adjusted Group outlook confirmed  


Bayer CEO Bill Anderson on Q1 2024


Two men in a suite in front of a blue background with the Bayer cross

Wolfgang Nickl

CFO of Bayer AG

Bill Anderson

CEO of Bayer AG